JAMA Otolaryngology–Head & Neck Surgery : Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma

Interview with Trisha M. Wise-Draper, MD, PhD author of Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD MBA.

Related Content:

• Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma